Page last updated: 2024-09-03

garenoxacin and clorgyline

garenoxacin has been researched along with clorgyline in 1 studies

Compound Research Comparison

Studies
(garenoxacin)
Trials
(garenoxacin)
Recent Studies (post-2010)
(garenoxacin)
Studies
(clorgyline)
Trials
(clorgyline)
Recent Studies (post-2010) (clorgyline)
19519461,07523170

Protein Interaction Comparison

ProteinTaxonomygarenoxacin (IC50)clorgyline (IC50)
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.8602
Amine oxidase [flavin-containing] A Rattus norvegicus (Norway rat)0.5688
Amine oxidase [flavin-containing] AHomo sapiens (human)0.2574
Amine oxidase [flavin-containing] A Bos taurus (cattle)0.0032
Amine oxidase [flavin-containing] BHomo sapiens (human)3.6869

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Song, Q; Tan, Z; Xiao, G; Xu, R; Yang, X1

Other Studies

1 other study(ies) available for garenoxacin and clorgyline

ArticleYear
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Bioorganic & medicinal chemistry, 2017, 03-15, Volume: 25, Issue:6

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cholinesterase Inhibitors; Humans; Kinetics; Models, Molecular; Monoamine Oxidase Inhibitors; Thioxanthenes; Xanthones

2017